AbbVie, Inc.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US00287Y1091
USD
228.71
-1.53 (-0.66%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
15,423.00
13,343.00
15,102.00
14,460.00
14,462.00
12,310.00
14,301.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
15,423.00
13,343.00
15,102.00
14,460.00
14,462.00
12,310.00
14,301.00
Raw Material Cost
4,375.00
4,003.00
4,364.00
4,193.00
4,192.00
4,082.00
4,266.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
782.00
739.00
740.00
758.00
763.00
693.00
597.00
Selling and Distribution Expenses
3,117.00
3,276.00
3,760.00
4,175.00
3,328.00
3,300.00
3,058.00
Other Expenses
134.90
132.80
155.80
137.20
118.50
124.60
132.50
Total Expenditure (Excl Depreciation)
9,623.00
9,346.00
10,422.00
10,498.00
9,468.00
9,321.00
9,246.00
Operating Profit (PBDIT) excl Other Income
5800
3997
4680
3962
4994
2989
5055
Other Income
302.00
210.00
195.00
378.00
343.00
304.00
260.00
Operating Profit (PBDIT)
8,188.00
6,246.00
6,970.00
6,431.00
7,421.00
5,367.00
7,391.00
Interest
782.00
739.00
740.00
758.00
763.00
693.00
597.00
Exceptional Items
-3,766.00
-1,807.00
-6,404.00
-1,498.00
-2,428.00
-845.00
-3,506.00
Gross Profit (PBDT)
11,048.00
9,340.00
10,738.00
10,267.00
10,270.00
8,228.00
10,035.00
Depreciation
2,086.00
2,039.00
2,095.00
2,091.00
2,084.00
2,074.00
2,076.00
Profit Before Tax
1,554.00
1,661.00
-2,269.00
2,084.00
2,146.00
1,755.00
1,212.00
Tax
613.00
372.00
-2,246.00
520.00
773.00
383.00
388.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
928.00
1,276.00
-32.00
1,551.00
1,360.00
1,359.00
811.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
928.00
1,276.00
-32.00
1,551.00
1,360.00
1,359.00
811.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
3.00
3.00
-1.00
3.00
3.00
3.00
2.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
931.00
1,279.00
-33.00
1,554.00
1,363.00
1,362.00
813.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
-183.00
1,420.00
3,325.00
6,032.00
6,778.00
8,007.00
10,360.00
Earnings per share (EPS)
0.52
0.72
-0.02
0.88
0.77
0.77
0.46
Diluted Earnings per share
0.52
0.72
-0.02
0.88
0.77
0.77
0.46
Operating Profit Margin (Excl OI)
37.61%
29.96%
30.99%
27.4%
34.53%
24.28%
35.35%
Gross Profit Margin
23.6%
27.73%
-1.15%
28.87%
29.25%
31.1%
22.99%
PAT Margin
6.02%
9.56%
-0.21%
10.73%
9.4%
11.04%
5.67%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2025 is 6.65% vs 4.31% in Jun 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2025 is -31.69% vs -32.39% in Jun 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2025 is 11.42% vs 0.51% in Jun 2024

stock-summary

Interest

YoY Growth in quarter ended Jun 2025 is 2.49% vs 29.98% in Jun 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024

Compare Quarterly Results Of AbbVie, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
15,423.00
23,741.00
-8,318.00
-35.04%
Other Operating Income
0.00
0.00
0.00
Total Operating income
15,423.00
23,741.00
-8,318.00
-35.04%
Raw Material Cost
4,375.00
7,481.00
-3,106.00
-41.52%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
782.00
432.00
350.00
81.02%
Selling and Distribution Expenses
3,117.00
5,889.00
-2,772.00
-47.07%
Other Expenses
134.90
310.00
-175.10
-56.48%
Total Expenditure (Excl Depreciation)
9,623.00
16,902.00
-7,279.00
-43.07%
Operating Profit (PBDIT) excl Other Income
5,800.00
6,839.00
-1,039.00
-15.19%
Other Income
302.00
534.00
-232.00
-43.45%
Operating Profit (PBDIT)
8,188.00
9,316.00
-1,128.00
-12.11%
Interest
782.00
432.00
350.00
81.02%
Exceptional Items
-3,766.00
-450.00
-3,316.00
-736.89%
Gross Profit (PBDT)
11,048.00
16,260.00
-5,212.00
-32.05%
Depreciation
2,086.00
1,943.00
143.00
7.36%
Profit Before Tax
1,554.00
6,491.00
-4,937.00
-76.06%
Tax
613.00
954.00
-341.00
-35.74%
Provisions and contingencies
0
0
0.00
Profit After Tax
928.00
5,537.00
-4,609.00
-83.24%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
928.00
5,537.00
-4,609.00
-83.24%
Share in Profit of Associates
0
0
0.00
Minority Interest
3.00
0.00
3.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
931.00
5,537.00
-4,606.00
-83.19%
Equity Capital
0
0
0.00
Face Value
0.01
1.00
0.00
Reserves
-183.00
78,473.00
-78,656.00
-100.23%
Earnings per share (EPS)
0.52
2.29
-1.77
-77.29%
Diluted Earnings per share
0.52
2.29
-1.77
-77.29%
Operating Profit Margin (Excl OI)
37.61%
28.81%
0.00
8.80%
Gross Profit Margin
23.60%
35.53%
0.00
-11.93%
PAT Margin
6.02%
23.32%
0.00
-17.30%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,542.30 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 15.59% vs -11.65% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 6.65% vs 4.31% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 93.10 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -27.21% vs 3,975.76% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -31.69% vs -32.39% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 788.60 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 30.65% vs -10.91% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 11.42% vs 0.51% in Jun 2024

Quarterly - Interest
Interest 78.20 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 5.82% vs -0.14% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 2.49% vs 29.98% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 37.61%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024